The present review reports the antifungal activity of mushroom extracts and isolated compounds including high (e.g. peptides and proteins) and low (e.g. sesquiterpenes and other terpenes, steroids, organic acids, acylcyclopentenediones and quinolines) molecular weight compounds. Most of the studies available on literature focused on screening of antifungal activity of mushroom extracts, rather than of isolated compounds. Data indicate that mushroom extracts are mainly tested against different Candida species, while mushroom compounds are mostly tested upon other fungi.
Introduction
Medicinal mushrooms have an established history of use in traditional oriental therapies. Modern clinical practice in Japan, China, Korea, and other Asian countries continues to rely on mushroom-derived preparations. Mushrooms have been used for many years in oriental culture as tea and nutritional food and because of their special fragrance and texture [1] . While the usage of medicinal mushrooms has a long tradition in Eastern countries, in Western countries it has increased only slightly since the last decades [2] .
Natural compounds with biological activity are normally present in plants, mushrooms and other natural sources. Mushrooms need antibacterial and antifungal compounds to survive in their natural environments. Therefore, antifungal compounds with more or less strong activities could be isolated from many mushroom species and could be beneficial for humans [3] .
Pathogenic fungi cause considerable damage in humans, farm animals, crops, and other organisms. Fungal infections can be devastating with a serious effect on health or lead to enormous economic losses. The organism has the innate ability to fight fungal invasions producing antifungal substances; however in immunocompromised individuals, this innate ability is diminished and fungal infections assume greater relevance. Furthermore, in agriculture, fungal invasion brings about serious reduction in the quality and yield of crops and incurs enormous economic losses. Research on antifungal compounds may provide ways to tackle the problem, introducing genes encoding antifungal proteins into crops to boost their resistance against fungal pathogens [4, 5] .
So, the use of mushrooms with potential therapeutic properties raises global interests from the scientific and clinical community based on two main reasons. First, mushrooms demonstrate their efficiency against numerous diseases and metabolic disorders as serious as cancer or degenerative diseases. Secondly, fungal bioactive metabolites can be obtained from many origins (wild and cultivated fruiting bodies or from mycelial biomass and supernatant of submerged cultured using bioreactors) [6] .
Following our previous review on antibacterial activity of mushroom extracts and isolated compounds [7] , in the present report we intend to give an overview about the antifungal potential of mushrooms and highlight some of the compounds identified and isolated from them.
The databases searched were Medline (1999 to August 2012) and Web of Science (1999 to August 2012) including scientific articles and conference proceedings. Search terms were: 'mushrooms', 'antifungal activity' and 'antifungal'. An exhaustive literature search was performed, but only mushroom extracts and isolated compounds with positive results were included.
In the scientific articles revised, different methodologies have been used to access antimicrobial activity of mushrooms extracts and compounds, including microdilution method, disk diffusion method, agar streak dilution method based in radial diffusion and a method with incorporation of the extract in the culture medium and further determination of viable cell numbers. Therefore, the results for antimicrobial activity may be expressed in different units.
Microdilution method comprises microdilutions of the extract in liquid medium using microplates to determine MIC (minimal inhibitory concentration) or IC 50 (concentration inhibiting 50% of the growth) values. In disk diffusion method, the extract is incorporated in disks at different concentrations, and the halo of growth inhibition is determined and represented by IZD (internal zone diameter) values. The agar streak dilution method based in radial diffusion is most widely used in extracts and implies the extract application in circular holes made in solid medium. The result might be expressed in IZD or MIC values. Regarding the fourth method, the extract is incorporated in the culture medium and, then, colony-forming units (CFU) are
determined. Mycelial Growth Inhibition Test is the method based in Poison Food
Technique. Percentage inhibition of mycelial growth is calculated by comparing the colony diameter of poisoned plate and non-poisoned plate [7] . Most of conventional antifungal drugs act in the plasmatic membrane, mainly in ergosterol metabolism. Two examples are fluconazole and ketoconazole, from the azoles group, which is characterized by inhibiting P-450 enzyme responsible for the ergosterol synthesis; ninestine interfers in the permeability and transport functions [8] .
Antifungal activity

Mushroom species with reported antifungal activity
As far as we know, 52 species were reported as having antifungal activity ( Table 1) ; most of them are edible mushrooms (44 referenced from among 52 species). Despite the lower interest of researchers for non-edible mushrooms in comparison with edible species, they also contain different metabolites that can be used in pharmaceutical products.
Most of the mushrooms that revealed antifungal activity are wild, allowing a higher diversity among the studied species. Mushrooms cultivation requires several specific conditions, being hard to obtain them. There are several factors influencing mushrooms cultivation, mainly environmental and physiological conditions, as also the existence of plagues. According to Pinna et al. [9] , the soil conditions affect the phenotype of all mushrooms, although each species has a specific answer. A good example is the soil humidity that can stimulate (e.g. Boletus edulis and Lactarius deterrimus) or delay (Cortinarius caperatus and Catathelasma ventricosum) the initial fructification period.
Furthermore, the presence of insects, mites, crustaceans and other arthropods decomposing synthetic substrates or wood used in mushrooms cultivation, has been reported as compromising their growth [10] . Other study also reports that substrates supplemented with sodium carbonate precipitate (CaCO 3 ) increase the yield and size of shiitake mushroom (Lentinus edodes) [11] . Therefore, due to all mentioned problems, only a limited number of species is cultivated and the best way to get a wide variety of mushrooms is collecting them from the natural and original habitats.
As Table 1 shows, the most studied mushrooms regarding antifungal properties are from Turkey and China. Twenty one species are exclusively saprotrophic, decomposing dead organic matter, and being very important to the ecosystem balance. Sixteen species are mycorrhizal, which establish symbiotic relationships with the roots of plants and trees, and six are biotrophic parasites, infecting a host and taking benefit from this relationship. Four species are necrotrophic parasite fungi that kill the host and then continue to feed on dead matter, passing to saprotrophic; finally five species are saprotrophic but also mycorrhizal.
Mushroom extracts with reported antifungal activity
Different extracts obtained from several mushroom species were described in literature as possessing antifungal activity ( Table 2) .
Regarding Agaricus species, Öztürk et al. [12] 
Mushroom isolated compounds with reported antifungal activity
Most studies on mushrooms with antifungal activity describe the action of its extracts without identifying the compounds responsible for this activity. However, some low molecular weight (LMW; Figure 1 ) and high molecular weight (HMW) compounds have been described as active against fungi ( Table 3) .
The LMW terpene compound grifolin (1) seems to have the highest antifungal activity
[15], but other LMW compounds also showed some activity (e.g., rufuslactone (2), enokipodim F,G,I (3a-c), cloratin A (5) and 2-aminoquinoline (13).
The sesquiterpene rufuslactone (2), showed activity against some phytopathogenic fungi such as Alternaria alternata, A. brassicae, Botrytis cinerea and Fusarium graminearum. Three steroids: 5α-ergost-7-en-3β-ol (8), 5α-ergost-7,22-dien-3β-ol (9) and 5,8-epidioxy-5α,8α-ergosta-6,22-dien-3β-ol (10) and five terpenes: applanoxidic acid A, C, F, G and H (11a,b; 12a-c), isolated from Ganoderma annulare, revealed activity against Microsporum canis and Trichophyton mentagrophytes. Applanoxidic acid A (11a) showed the best activity against the mentioned fungi, and particularly for Trichophyton mentagrophytes it showed higher activity (MIC=500 µg/mL) than the positive control (fluconazole; MIC= 0.6 µg/mL). According to the obtained data, the antifungal activity observed for the mentioned compounds is not comparable to the most used antibiotics for fungal diseases; nevertheless, future studies can modify the mentioned compounds in order to increase their antifungal activity [29].
2-Aminoquinoline (13) has been described in several studies showing broad spectra of biological activities. A weak activity of this LMW compound was reported against Penicillium inflatum and Streptomyces galilaeus. The concentration of this quinoline in the mushroom is 40 times higher than the one used in the assay [30] .
HMW compounds with antifungal properties were also isolated from mushrooms ( Peptides with antifungal activity were also described as pleurostrin, isolated from Pleurotus ostreatus, which showed activity against Fusarium oxysporum, Mycosphaerella arachidicola and Physalospora piricola [4] . 
Concluding remarks
The present review focuses on antifungal effects of mushrooms from all over the world, and their isolated compounds; it will be certainly useful for future scientific studies.
Nonetheless, the comparison of the results reported by different authors is difficult, due to the diverse methodologies used to evaluate antifungal activity of mushroom extracts or isolated compounds. Therefore, the standardization of methods and establishment of cut-off values is necessary.
Data available from literature indicates that mushroom extracts are mainly tested against different Candida species, while mushroom compounds are mostly tested in other fungi (e.g., food contaminants). Therefore, most of those compounds might be more useful in food industry than in clinics.
Oudemansiella canarii and Agaricus bisporus methanolic extracts proved to be the best ones against Candida sp.. Regarding mushroom compounds, grifolin (2) isolated from
Albatrellus dispansus seemed to be the best option against phytopathogenic fungi.
Further studies should be performed in order to deeply understand the activity of some mushroom extracts against Candida sp. and the mechanism of action of these compounds against phytopathogenic fungi. Cytotoxicity assays will also be important to evaluate the effects on human in the range of the in vitro tested concentrations.
Most of the studies available on literature focused on screening of antifungal activity of mushroom extracts, rather than of isolated compounds. After elucidation of their mechanism of action, LMW or HMW mushroom compounds could be used to develop antifungals for pathogenic or contaminant microorganisms.
Abbreviations
IC 50
Concentration inhibiting 50% of the growth M-mycelium, the other samples refer to fruiting body. The antimicrobial activity was expressed in GI (growth inhibition percentages), CFU (colony-forming unities), MIC (minimal inhibitory concentrations) or IZD (internal zone diameter) values.
